Skip to main content

Published locations for Sustained response at 2 years reported for newly approved oral psoriasis agent

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Sustained response at 2 years reported for newly approved oral psoriasis agent

User login

  • Reset your password
  • /content/sustained-response-2-years-reported-newly-approved-oral-psoriasis-agent
  • /clinicianreviews/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /edermatologynews/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /familypracticenews/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /fedprac/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral-psoriasis
  • /internalmedicinenews/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved
  • /rheumatologynews/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /rheumatology/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /internalmedicine/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /dermatology/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /familymedicine/article/257871/psoriasis/sustained-response-2-years-reported-newly-approved-oral
  • /psoriatic-arthritis-icymi/article/257871/psoriasis/sustained-response-2-years-reported-newly